Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency ...

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...

Lupin is the exclusive first-to-file for this product, and it will be manufactured at its Pithampur facility in India. Bromfenac Ophthalmic Solution, 0.075% is indicated for the treatment of ...

Generally, you’ll then see them start to bloom in June, but this all depends on when you planted the lupin seeds in the first ...

(Photo: Company Website) Global pharma major Lupin Limited on Tuesday announced the launch of the first generic version of Pred Forte (Prednisolone Acetate) Ophthalmic Suspension USP, 1% in the ...

The company posted a net profit of Rs 852.6 crore in the quarter ended September in comparison to Rs 489.7 crore in the ...

Lupin’s average revenue will potentially increase 9.2 per cent Y-o-Y to Rs 5,502 crore as against Rs 5,038 crore in Q2FY24.

Warner Bros. Discovery is adapting the Harry Potter novels all over again – this time as a TV series – and it’s hard to ...

CEO Vinita Gupta stated that Lupin expects to maintain a quarterly range of $220-230 million for its US business, driven by ...

Lupin Q2 Results Live : Lupin declared their Q2 results on November 7, 2024, reporting a robust performance with a topline ...

Lupin Ltd (BOM:500257) reports robust financial performance with significant gains in India and US markets, while navigating competitive challenges and FDA compliance issues.

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to treat Type II diabetes and obesity, Lupin top-brass said. This segment of ...